Advertisement

Ads Placeholder
Loading...

Biofrontera AG

B8FK.DE•XETRA
Healthcare
Drug Manufacturers - Specialty & Generic
€2.49
€-0.09(-3.49%)
German Market opens in 1h 24m

Biofrontera AG (B8FK.DE) Stock Overview

Explore Biofrontera AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap15.1M
P/E Ratio-430.57
EPS (TTM)$-0.36
ROE-0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$2.79
3 Months$2.76
1 Year Target$10.01

B8FK.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biofrontera AG (B8FK.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -430.57 and a market capitalization of 15.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.49%
5-Day Change
5.06%
1-Month Change
-5.68%
3-Month Change
-0.80%
6-Month Change
-10.75%
Year-to-Date (YTD) Change
-0.80%
1-Year Change
0.40%
3-Year Change
-90.28%
5-Year Change
-95.06%
All-Time (Max) Change
-99.03%

Contact Information

https://www.biofrontera.com
49 214 87632 0
Hemmelrather Weg 201, Leverkusen, NaN, 51377

Company Facts

750 Employees
IPO DateOct 31, 2006
CountryDE
Actively Trading

Frequently Asked Questions